National Institute of Biomedical Imaging and Bioengineering; Notice of Meeting, 59564-59565 [E9-27713]

Download as PDF 59564 Federal Register / Vol. 74, No. 221 / Wednesday, November 18, 2009 / Notices of 46, the Tsaile PHS Indian Health Center would receive priority over the Chinle Comprehensive Health Care Facility. Dated: November 6, 2009. Yvette Roubideaux, Director, Indian Health Service. [FR Doc. E9–27721 Filed 11–17–09; 8:45 am] BILLING CODE 4165–16–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration Advisory Committee on Heritable Disorders in Newborns and Children; Notice of Meeting mstockstill on DSKH9S0YB1PROD with NOTICES In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), notice is hereby given of the following meeting: Name: Secretary’s Advisory Committee on Heritable Disorders in Newborns and Children. Dates and Times: January 21, 2010, 8:30 a.m. to 5 p.m. January 22, 2010, 8:30 a.m. to 3 p.m. Place: Washington Marriott at Metro Center, 775 12th Street, NW., Washington, DC 20005. Status: The meeting will be open to the public with attendance limited to space availability. Participants are asked to register for the meeting by going to the registration Web site at https://events.SignUp4.com/ ACHDNC0110. The registration deadline is Tuesday, January 19, 2010. Individuals who need special assistance, such as sign language interpretation or other reasonable accommodations should indicate their needs on the registration Web site. The deadline for special accommodation requests is Friday, January 15, 2010. If there are technical problems gaining access to the Web site, please contact Feven Habteab, Meetings Coordinator at conferences@altarum.org. Purpose: The Secretary’s Advisory Committee on Heritable Disorders in Newborns and Children (Advisory Committee) was established to advise and guide the Secretary regarding the most appropriate application of universal newborn screening tests, technologies, policies, guidelines and programs for effectively reducing morbidity and mortality in newborns and children having or at risk for heritable disorders. The Advisory Committee also provides advice and recommendations concerning the grants and projects authorized under the Public Health Service Act, 42 U.S.C. 300b-10, (Heritable Disorders Program) as amended in the Newborn Screening Saves Lives Act of 2008. Agenda: The meeting will include: (1) A presentation of the External Review Workgroup’s preliminary report on the nomination of Alpha-Thalassemia (Hemoglobin H) disease to the Advisory Committee’s uniform newborn screening VerDate Nov<24>2008 16:30 Nov 17, 2009 Jkt 220001 panel; (2) a discussion of the Advisory Committee’s final draft of the report on the use and storage of newborn screening Residual Blood Spots; (3) an update on the development of the Newborn Screening Information Clearinghouse; and (4) presentations on the continued work and reports of the Advisory Committee’s subcommittees on laboratory standards and procedures, follow-up and treatment, and education and training. Proposed Agenda items are subject to change as priorities dictate. You can locate the Agenda, Committee Roster and Charter, presentations, and meeting materials at the home page of the Advisory Committee’s Web site at https://www.hrsa.gov/ heritabledisorderscommittee/. Web cast: The meeting will be Web cast. Information on how to access the Web cast will be available one week prior to the meeting, January 14, 2010, by clicking on the meeting date link at https:// events.SignUp4.com/ACHDNC0110. Public Comments: Members of the public can present oral comments during the public comment periods of the meeting, which are scheduled for both days of the meeting. Those individuals who want to make a comment are requested to register online by Tuesday, January 19, 2010 at https:// events.SignUp4.com/ACHDNC0110. Requests will contain the name, address, telephone number, and any professional or business affiliation of the person desiring to make an oral presentation. Groups having similar interests are requested to combine their comments and present them through a single representative. The list of public comment participants will be posted on the Web site. Written comments should be e-mailed via email no later than Tuesday, January 19, 2010 for consideration. Comments should be submitted to Feven Habteab, Meetings Coordinator, Conference and Meetings Management, Altarum Institute, 1200 18th Street, NW., Suite 700, Washington, DC 20036, telephone: 202 828–5100; fax: 202 785–3083, or e-mail: conferences@altarum.org. Contact Person: Anyone interested in obtaining other relevant information should write or contact Alaina M. Harris, Maternal and Child Health Bureau, Health Resources and Services Administration, Room 18A–19, Parklawn Building, 5600 Fishers Lane, Rockville, Maryland 20857, Telephone (301) 443–0721, aharris@hrsa.gov. More information on the Advisory Committee is available at https://mchb.hrsa.gov/ heritabledisorderscommittee. Dated: November 12, 2009. Alexandra Huttinger, Director, Division of Policy Review and Coordination. [FR Doc. E9–27660 Filed 11–17–09; 8:45 am] BILLING CODE 4165–15–P PO 00000 Frm 00045 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Biomedical Imaging and Bioengineering; Notice of Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of a meeting of the National Advisory Council for Biomedical Imaging and Bioengineering. The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and/or contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications and/or contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Advisory Council for Biomedical Imaging and Bioengineering; NACBIB, January, 2010. Date: December 11, 2009. Open: 9 a.m. to 1 p.m. Agenda: Report from the Institute Director, other Institute Staff and presentations of working group reports. Place: Bethesda Marriott Suites, 6711 Democracy Boulevard, Independence Room (2nd Level), Bethesda, MD 20817. Closed: 1 p.m. to 3:30 p.m. Agenda: To review and evaluate grant applications and/or proposals. Place: Bethesda Marriott Suites, 6711 Democracy Boulevard, Independence Room (2nd Level), Bethesda, MD 20817. Contact Person: Anthony Demsey, PhD, Director, National Institute of Biomedical Imaging and Bioengineering, 6701 Democracy Boulevard, Room 241, Bethesda, MD 20892. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. Information is also available on the Institute’s/Center’s home page: https:// www.nibib1.nih.gov/about/NACBIB/ NACBIB.htm, where an agenda and any E:\FR\FM\18NON1.SGM 18NON1 Federal Register / Vol. 74, No. 221 / Wednesday, November 18, 2009 / Notices additional information for the meeting will be posted when available. Dated: November 12, 2009. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E9–27713 Filed 11–17–09; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Dental & Craniofacial Research; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. mstockstill on DSKH9S0YB1PROD with NOTICES Name of Committee: National Institute of Dental and Craniofacial Research Special Emphasis Panel; Review PAR–07–332 T32. Date: January 13, 2010. Time: 12 p.m. to 1 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Mary Kelly, Scientific Review Officer, Scientific Review Branch, National Inst of Dental & Craniofacial Research, NIH 6701 Democracy Blvd., room 672, MSC 4878, Bethesda, MD 20892–4878, 301–594–4809, mary_kelly@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.121, Oral Diseases and Disorders Research, National Institutes of Health, HHS) Dated: November 12, 2009. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E9–27712 Filed 11–17–09; 8:45 am] BILLING CODE 4140–01–P VerDate Nov<24>2008 16:30 Nov 17, 2009 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Eunice Kennedy Shriver National Institute of Child Health & Human Development; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Child Health and Human Development Special Emphasis Panel, Functions and Development of the Mirror Neuron System. Date: December 8, 2009. Time: 1 p.m. to 4:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6100 Executive Blvd., Room 5B01, Bethesda, MD (Telephone Conference Call). Contact Person: Marita R. Hopmann, PhD, Scientific Review Officer, Division of Scientific Review Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, 6100 Building, Room 5B01, Bethesda, MD 20892, (301) 435– 6911, hopmannm@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.864, Population Research; 93.865, Research for Mothers and Children; 93.929, Center for Medical Rehabilitation Research; 93.209, Contraception and Infertility Loan Repayment Program, National Institutes of Health, HHS) Dated: November 12, 2009. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E9–27711 Filed 11–17–09; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Center for Research Resources; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. Jkt 220001 PO 00000 Frm 00046 Fmt 4703 Sfmt 4703 59565 The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Center for Research Resources Special Emphasis Panel; ARRA STRB DEC. MTG.–1. Date: December 7–11, 2009. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, One Democracy Plaza, 6701 Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Barbara J. Nelson, PhD, Scientific Review Officer, Office of Review, National Center for Research Resources, 6701 Democracy Blvd. Room 1080, 1 Democracy Plaza, Bethesda, MD 20892, 301–435–0806, nelsonbj@mail.nih.gov. Name of Committee: National Center for Research Resources Special Emphasis Panel; ARRA STRB DEC. MTG.–2. Date: December 7–11, 2009. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Bethesda, MD (Telephone Conference Call). Contact Person: Barbara J. Nelson, PhD, Scientific Review Officer, Office of Review, National Center for Research Resources, 6701 Democracy Blvd., Room 1080, 1 Democracy Plaza, Bethesda, MD 20892, 301–435–0806, nelsonbj@mail.nih.gov. Name of Committee: National Center for Research Resources Special Emphasis Panel; ARRA STRB DEC. MTG.–3. Date: December 7–11, 2009. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Bethesda, MD (Telephone Conference Call). Contact Person: Carol Lambert, PhD, Scientific Review Officer, Office of Review, National Center for Research Resources, 6701 Democracy Blvd., 1 Democracy Plaza, Room 1076, Bethesda, MD 20892, 301–435–0814, lambert@mail.nih.gov. Name of Committee: National Center for Research Resources Special Emphasis Panel; ARRA STRB DEC. MTG.–4. Date: December 7–11, 2009. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Bethesda, MD (Telephone Conference Call). Contact Person: Carol Lambert, PhD, Scientific Review Officer, Office of Review, National Center for Research Resources, 6701 Democracy Blvd., 1 Democracy Plaza, Room E:\FR\FM\18NON1.SGM 18NON1

Agencies

[Federal Register Volume 74, Number 221 (Wednesday, November 18, 2009)]
[Notices]
[Pages 59564-59565]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-27713]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Biomedical Imaging and Bioengineering; 
Notice of Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of a meeting of the 
National Advisory Council for Biomedical Imaging and Bioengineering.
    The meeting will be open to the public as indicated below, with 
attendance limited to space available. Individuals who plan to attend 
and need special assistance, such as sign language interpretation or 
other reasonable accommodations, should notify the Contact Person 
listed below in advance of the meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and/or contract proposals 
and the discussions could disclose confidential trade secrets or 
commercial property such as patentable material, and personal 
information concerning individuals associated with the grant 
applications and/or contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Advisory Council for Biomedical 
Imaging and Bioengineering; NACBIB, January, 2010.
    Date: December 11, 2009.
    Open: 9 a.m. to 1 p.m.
    Agenda: Report from the Institute Director, other Institute 
Staff and presentations of working group reports.
    Place: Bethesda Marriott Suites, 6711 Democracy Boulevard, 
Independence Room (2nd Level), Bethesda, MD 20817.
    Closed: 1 p.m. to 3:30 p.m.
    Agenda: To review and evaluate grant applications and/or 
proposals.
    Place: Bethesda Marriott Suites, 6711 Democracy Boulevard, 
Independence Room (2nd Level), Bethesda, MD 20817.
    Contact Person: Anthony Demsey, PhD, Director, National 
Institute of Biomedical Imaging and Bioengineering, 6701 Democracy 
Boulevard, Room 241, Bethesda, MD 20892.

    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    Information is also available on the Institute's/Center's home 
page: https://www.nibib1.nih.gov/about/NACBIB/NACBIB.htm, where an 
agenda and any

[[Page 59565]]

additional information for the meeting will be posted when 
available.

    Dated: November 12, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-27713 Filed 11-17-09; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.